相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thyroid cytology smear slides: An untapped resource for ThyroSeq testing
Marina N. Nikiforova et al.
CANCER CYTOPATHOLOGY (2021)
New Horizons: Emerging Therapies and Targets in Thyroid Cancer
Matthew D. Ringel
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples
Cihan Kaya et al.
THYROID (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with RET Gene Mutations or Fusions
Diana Bradford et al.
CLINICAL CANCER RESEARCH (2021)
Pitfalls in RET Fusion Detection Using Break-part FISH Probes in Papillary Thyroid Carcinoma
Yuanyuan Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The importance of the RET gene in thyroid cancer and therapeutic implications
Domenico Salvatore et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Thyroid cancer incidence trends by histology in 25 countries: a population-based study
Adalberto Miranda-Filho et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
A worldwide journey of thyroid cancer incidence centred on tumour histology
Esther Diana Rossi et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer
Pasquale Pisapia et al.
FRONTIERS IN MEDICINE (2021)
FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With RET Gene Mutations or Fusions
Janice Kim et al.
CLINICAL CANCER RESEARCH (2021)
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
Marcia S. Brose et al.
LANCET ONCOLOGY (2021)
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
Vivek Subbiah et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution
Tommaso Porcelli et al.
ENDOCRINE (2021)
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy
Claudio Bellevicine et al.
CANCER CYTOPATHOLOGY (2020)
State-of-the-Art Strategies for Targeting RET-Dependent Cancers
Vivek Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Advances in Targeting RET-Dependent Cancers
Vivek Subbiah et al.
CANCER DISCOVERY (2020)
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues
Massimo Santoro et al.
GENES (2020)
Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors
Natalia Magdalena Chrzanowska et al.
MOLECULES (2020)
Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel
Ali S. Alzahrani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review
Rossella Bruno et al.
DIAGNOSTICS (2020)
RET,NTRK,ALK,BRAF, andMETFusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas
Barbora Pekova et al.
THYROID (2020)
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
L. J. Wirth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
Maria E. Cabanillas et al.
ENDOCRINE REVIEWS (2019)
Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples
Trevor E. Angell et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis
Thomas Johannes Musholt et al.
EJSO (2019)
Structure and function of RET in multiple endocrine neoplasia type 2
Ivan Plaza-Menacho
ENDOCRINE-RELATED CANCER (2018)
Selective RET kinase inhibition for patients with RET-altered cancers
V. Subbiah et al.
ANNALS OF ONCOLOGY (2018)
Analytical Performance of the ThyroSeq v3 Genomic Classifier for Cancer Diagnosis in Thyroid Nodules
Marina N. Nikiforova et al.
CANCER (2018)
65 YEARS OF THE DOUBLE HELIX Exploiting insights on the RET receptor for personalized cancer medicine
Lois M. Mulligan
ENDOCRINE-RELATED CANCER (2018)
Precision Targeted Therapy with BLU-667 for RET-Driven Cancers
Vivek Subbiah et al.
CANCER DISCOVERY (2018)
The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases
Vicky W. W. Tsai et al.
CELL METABOLISM (2018)
Antitumor Activity of RXDX-105 in Multiple Cancer Types with RET Rearrangements or Mutations
Gang G. Li et al.
CLINICAL CANCER RESEARCH (2017)
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients
Shumei Kato et al.
CLINICAL CANCER RESEARCH (2017)
Differential roles of RET isoforms in medullary and papillary thyroid carcinomas
Eric Y. Lian et al.
ENDOCRINE-RELATED CANCER (2017)
A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study
Alain Ravaud et al.
EUROPEAN JOURNAL OF CANCER (2017)
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
Hyeyeun Lim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
Oliver Gautschi et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
FRMD4A / RET : A Novel RET Oncogenic Fusion Variant in Non–Small Cell Lung Carcinoma
Vamsidhar Velcheti et al.
Journal of Thoracic Oncology (2017)
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Linda Yang et al.
NATURE MEDICINE (2017)
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes
Alexander Drilon et al.
Nature Reviews Clinical Oncology (2017)
Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany
Markus Eszlinger et al.
THYROID (2017)
Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1/GDF15 Pathway
Samuel N. Breit et al.
TRENDS IN MOLECULAR MEDICINE (2017)
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer
Valentina De Falco et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Next-generation sequencing in thyroid cancer
Yoon Jin Cha et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
Cristina Romei et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
The changing incidence of thyroid cancer
Cari M. Kitahara et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Biologic and Clinical Perspectives on Thyroid Cancer
James A. Fagin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements
Ivan Plaza-Menacho et al.
CELL REPORTS (2016)
Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective
E. Vigliar et al.
CYTOPATHOLOGY (2015)
An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer
Sun Min Lim et al.
EUROPEAN JOURNAL OF CANCER (2015)
RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma
Elizabeth G. Grubbs et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
An Evaluation and Recommendation of the Optimal Methodologies to Detect RET Gene Rearrangements in Papillary Thyroid Carcinoma
Tianwei Zhang et al.
GENES CHROMOSOMES & CANCER (2015)
Molecular Process Producing Oncogene Fusion in Lung Cancer Cells by Illegitimate Repair of DNA Double-Strand Breaks
Yoshitaka Seki et al.
BIOMOLECULES (2015)
Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe
Paola Caria et al.
CANCER CYTOPATHOLOGY (2014)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
Takashi Nakaoku et al.
CLINICAL CANCER RESEARCH (2014)
A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer
Maruja E. Lira et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Molecular Mechanisms Underlying Oncogenic RET Fusion in Lung Adenocarcinoma
Tatsuji Mizukami et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Oncogenic RET Kinase Domain Mutations Perturb the Autophosphorylation Trajectory by Enhancing Substrate Presentation In trans
Ivan Plaza-Menacho et al.
MOLECULAR CELL (2014)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose et al.
LANCET (2014)
Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies
Daniela Bossi et al.
MOLECULAR ONCOLOGY (2014)
The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function
Diogo Fonseca-Pereira et al.
NATURE (2014)
A novel RET rearrangement (ACBD5/RET) by pericentric inversion, inv(10)(p12.1;q11.2), in papillary thyroid cancer from an atomic bomb survivor exposed to high-dose radiation
Kiyohiro Hamatani et al.
ONCOLOGY REPORTS (2014)
Concomitant BRAFV600E Mutation and RET/PTC Rearrangement Is a Frequent Occurrence in Papillary Thyroid Carcinoma
Anna Guerra et al.
THYROID (2014)
Concomitant RAS, RET/PTC, or BRAF Mutations in Advanced Stage of Papillary Thyroid Carcinoma
Minjing Zou et al.
THYROID (2014)
The landscape of kinase fusions in cancer
Nicolas Stransky et al.
NATURE COMMUNICATIONS (2014)
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
Thomas Wiesner et al.
NATURE COMMUNICATIONS (2014)
RET Recognition of GDNF-GFRaα1 Ligand by a Composite Binding Site Promotes Membrane-Proximal Self-Association
Kerry M. Goodman et al.
CELL REPORTS (2014)
RET/PTC and PAX8/PPAR chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics
Rebecca J. Leeman-Neill et al.
CANCER (2013)
Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view
Paola Caria et al.
ENDOCRINE-RELATED CANCER (2013)
Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
Julio C. Ricarte-Filho et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Detection of BRAF p.V600E Mutations in Melanomas Comparison of Four Methods Argues for Sequential Use of Immunohistochemistry and Pyrosequencing
Emeline Colomba et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Central Role of RET in Thyroid Cancer
Massimo Santoro et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Structure and Physiology of the RET Receptor Tyrosine Kinase
Carlos F. Ibanez
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review
Anna Guerra et al.
BMC SURGERY (2013)
Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas
Alexander Drilon et al.
CANCER DISCOVERY (2013)
RET/PTC rearrangement is prevalent in follicular Hurthle cell carcinomas
Margriet M. de Vries et al.
HISTOPATHOLOGY (2012)
Eph receptors and ephrins as targets for cancer therapy
Hong-Qing Xi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years
Cristina Romei et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
Sophie Leboulleux et al.
LANCET ONCOLOGY (2012)
KIF5B-RET fusions in lung adenocarcinoma
Takashi Kohno et al.
NATURE MEDICINE (2012)
RET, ROS1 and ALK fusions in lung cancer
Kengo Takeuchi et al.
NATURE MEDICINE (2012)
RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
Cristina Romei et al.
Frontiers in Endocrinology (2012)
Sunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation
Woo-Jin Jeong et al.
CANCER BIOLOGY & THERAPY (2011)
Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples
Yuri E. Nikiforov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Role of H2O2 in RET/PTC1 Chromosomal Rearrangement Produced by Ionizing Radiation in Human Thyroid Cells
Rabii Ameziane-El-Hassani et al.
CANCER RESEARCH (2010)
RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components
Kunio Mochizuki et al.
HISTOPATHOLOGY (2010)
Protein-tyrosine Phosphatase SHP2 Contributes to GDNF Neurotrophic Activity through Direct Binding to Phospho-Tyr687 in the RET Receptor Tyrosine Kinase
Maurice Perrinjaquet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
c-Ret-mediated hearing loss in mice with Hirschsprung disease
Nobutaka Ohgami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose
Kiyohiro Hamatani et al.
CANCER RESEARCH (2008)
Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays
Brenda Summersgill et al.
NATURE PROTOCOLS (2008)
HOOK3-RET:: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma
Raffaele Ciampi et al.
ENDOCRINE-RELATED CANCER (2007)
The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth
Carmen Canibano et al.
EMBO JOURNAL (2007)
Minireview: RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
Raffaele Ciampi et al.
ENDOCRINOLOGY (2007)
Structure and chemical inhibition of the RET tyrosine kinase domain
Phillip P. Knowles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: Follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma
Kerry J. Rhoden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Ablation of persephin receptor glial cell line-derived neurotrophic factor family receptor α4 impairs thyroid calcitonin production in young mice
PH Lindfors et al.
ENDOCRINOLOGY (2006)
RET tyrosine kinase signaling in development and cancer
E Arighi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to γ-radiation:: A model of carcinogenic chromosomal rearrangement induced by ionizing radiation
CM Caudill et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival
M Encinas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma
KJ Rhoden et al.
LABORATORY INVESTIGATION (2004)
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
P Soares et al.
ONCOGENE (2003)
RET/PTC rearrangement in thyroid tumors
YE Nikiforov
ENDOCRINE PATHOLOGY (2002)
Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization
R Corvi et al.
LABORATORY INVESTIGATION (2001)
Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site
J Anders et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
MEN2A-RET-induced cellular transformation by activation of STAT3
JJ Schuringa et al.
ONCOGENE (2001)
Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase
V Besset et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor
H Hayashi et al.
ONCOGENE (2000)
Regulation of cell fate decision of undifferentiated spermatogonia by GDNF
XJ Meng et al.
SCIENCE (2000)
分享论文
